Onyx Scientific targets stateside expansion with new appointment Onyx Scientific targets stateside expansion with new appointment Leading small molecule CDMO Onyx Scientific is set to expand its commercial operations in the United States with the appointment of Anthony Harbour as Business Development... AES Clean Technology expands senior leadership team with key appointment AES Clean Technology expands senior leadership team with key appointment A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO) SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe Nuclera announces the appointment of Jonathan Milner as Chairman of the Board Nuclera announces the appointment of Jonathan Milner as Chairman of the Board Nuclera, the pioneer in bringing rapid protein prototyping to the benchtop, is delighted to announce the appointment of Jonathan Milner as the Non-executive Chairman of the... Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors Corteria Pharmaceuticals, a biopharmaceutical company specialised in the development of transformative therapies for heart failure and obesity, announces the appointment of... X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced executive management team changes aimed at expanding its position as a... 2cureX announces changes to the Board of Directors 2cureX announces changes to the Board of Directors 2cureX, a pioneer in the use of 3D tumoroids for predicting cancer treatment efficacy, is implementing significant changes in its governance resulting in four Board members... Stuart Quin joins GHO Capital as Partner Stuart Quin joins GHO Capital as Partner Former CEO of Medica Group and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer Appointment further strengthens SpliceBio’s leadership team as it accelerates lead programme targeting Stargardt disease towards clinical development Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites Sauer-Jones will be responsible for US API maker Veranova’s sites in Devens and North Andover Industry veteran Abbas Hussain appointed as Chair of Asceneuron Industry veteran Abbas Hussain appointed as Chair of Asceneuron This follows the appointment of Barbara Angehrn Pavik as Chief Executive Officer, signaling a concerted effort to propel the development of groundbreaking treatments aimed at... OM Pharma appoints Roch Ogier as Chief Executive Officer OM Pharma appoints Roch Ogier as Chief Executive Officer OM Pharma, a global biopharmaceutical company headquartered in Switzerland, announced the appointment of Roch Ogier as Chief Executive Officer (CEO), effective January 1, 2024 Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board The appointment supports ambitious commercialisation strategy for DNA synthesis platform, gSynth, and follows $10m Series A financing to scale operations Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer Appointment signifies a pivotal move for Astraveus as it expands its executive team to advance its groundbreaking cell and gene therapy (CGT) manufacturing solutions Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs),...